Europe - Frankfurt Stock Exchange - FRA:NPW1 - GB0009223206 - Common Stock
The current stock price of NPW1.DE is 14.3 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.28 | 114.42B | ||
| 1MDT.MI | MEDTRONIC PLC | 18.6 | 114.29B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.79 | 47.97B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.23 | 23.13B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.07 | 22.90B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.3 | 22.60B | ||
| BIM.PA | BIOMERIEUX | 28.5 | 13.02B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 160 | 4.81B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.96 | 4.12B | ||
| DIA.MI | DIASORIN SPA | 18.27 | 3.38B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.83 | 1.31B | ||
| DRW8.DE | DRAEGERWERK AG | 9.46 | 1.14B |
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
SMITH & NEPHEW PLC
Building 5, Croxley Park, Hatters Lane
Watford HERTFORDSHIRE GB
Employees: 17349
Phone: 4401923477100
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
The current stock price of NPW1.DE is 14.3 EUR. The price increased by 1.82% in the last trading session.
SMITH & NEPHEW PLC (NPW1.DE) has a dividend yield of 2.33%. The yearly dividend amount is currently 0.32.
NPW1.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
SMITH & NEPHEW PLC (NPW1.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
SMITH & NEPHEW PLC (NPW1.DE) currently has 17349 employees.
SMITH & NEPHEW PLC (NPW1.DE) will report earnings on 2026-02-23, after the market close.
ChartMill assigns a technical rating of 1 / 10 to NPW1.DE.
ChartMill assigns a fundamental rating of 5 / 10 to NPW1.DE. NPW1.DE has only an average score on both its financial health and profitability.
Over the last trailing twelve months NPW1.DE reported a non-GAAP Earnings per Share(EPS) of 0.48. The EPS increased by 59.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.26% | ||
| ROA | 4.59% | ||
| ROE | 8.87% | ||
| Debt/Equity | 0.6 |
23 analysts have analysed NPW1.DE and the average price target is 16.86 EUR. This implies a price increase of 17.9% is expected in the next year compared to the current price of 14.3.
For the next year, analysts expect an EPS growth of 28.32% and a revenue growth 6.38% for NPW1.DE